Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients : subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese"
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 64(2023), 10 vom: 05. Okt., Seite 1715-1718 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mele, Giuseppe [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4Z63YK6E0E |
|---|
| Anmerkungen: |
Date Completed 20.02.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/10428194.2023.2232487 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359185592 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359185592 | ||
| 003 | DE-627 | ||
| 005 | 20240301231958.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2023.2232487 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1313.xml |
| 035 | |a (DE-627)NLM359185592 | ||
| 035 | |a (NLM)37417467 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mele, Giuseppe |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients |b subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese" |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.02.2024 | ||
| 500 | |a Date Revised 01.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Bortezomib |2 NLM | |
| 650 | 7 | |a 69G8BD63PP |2 NLM | |
| 650 | 7 | |a daratumumab |2 NLM | |
| 650 | 7 | |a 4Z63YK6E0E |2 NLM | |
| 650 | 7 | |a Dexamethasone |2 NLM | |
| 650 | 7 | |a 7S5I7G3JQL |2 NLM | |
| 650 | 7 | |a Lenalidomide |2 NLM | |
| 650 | 7 | |a F0P408N6V4 |2 NLM | |
| 700 | 1 | |a Di Renzo, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Cascavilla, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Carella, Angelo Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Guarini, Attilio |e verfasserin |4 aut | |
| 700 | 1 | |a Mazza, Patrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Melillo, Lorella |e verfasserin |4 aut | |
| 700 | 1 | |a Pavone, Vincenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Tarantini, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Curci, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Falcone, Anna P |e verfasserin |4 aut | |
| 700 | 1 | |a Germano, Candida |e verfasserin |4 aut | |
| 700 | 1 | |a Mele, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Merchionne, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Palazzo, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Palumbo, Gaetano |e verfasserin |4 aut | |
| 700 | 1 | |a Quinto, Angela Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Reddiconto, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Rossini, Bernardo |e verfasserin |4 aut | |
| 700 | 1 | |a Spina, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Sgherza, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Specchia, Giorgina |e verfasserin |4 aut | |
| 700 | 1 | |a Musto, Pellegrino |e verfasserin |4 aut | |
| 700 | 1 | |a Pastore, Domenico |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 64(2023), 10 vom: 05. Okt., Seite 1715-1718 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:64 |g year:2023 |g number:10 |g day:05 |g month:10 |g pages:1715-1718 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2023.2232487 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 64 |j 2023 |e 10 |b 05 |c 10 |h 1715-1718 | ||